Edwards Lifesciences Corporation Increase (Decrease) in Income Taxes Payable
Edwards Lifesciences Corporation (EW) reported Increase (Decrease) in Income Taxes Payable of $53.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-04
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was $12.00M.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $41.90M, a 18.16% decline year-over-year.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $57.60M.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$10.20M, a 101.52% decline year-over-year.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for fiscal 2025 was -$141.80M.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for fiscal 2024 was -$186.70M.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for fiscal 2023 was -$5.80M.
- Edwards Lifesciences Corporation increase (decrease) in income taxes payable for fiscal 2022 was -$5.60M, a 109.03% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $53.90M 10-Q · filed 2026-08-04 | $111.50M derived: sum of 3 quarters · filed 2026-08-04 | $101.30M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $41.90M 10-Q · filed 2026-05-06 | $99.50M derived: sum of 2 quarters · filed 2026-05-06 | $89.30M derived: sum of 3 quarters · filed 2026-05-06 | -$151.10M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $57.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $47.40M derived: sum of 2 quarters · filed 2026-02-25 | -$193.00M derived: sum of 3 quarters · filed 2026-08-04 | -$141.80M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | -$10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$250.60M derived: sum of 2 quarters · filed 2026-08-04 | -$199.40M 10-Q · filed 2025-11-05 | -$687.90M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$240.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$189.20M 10-Q · filed 2026-08-04 | -$677.70M derived: sum of 3 quarters · filed 2026-08-04 | -$5.90M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $51.20M 10-Q · filed 2026-05-06 | -$437.30M derived: sum of 2 quarters · filed 2026-05-06 | $234.50M derived: sum of 3 quarters · filed 2026-05-06 | $127.60M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$488.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $183.30M derived: sum of 2 quarters · filed 2026-02-25 | $76.40M derived: sum of 3 quarters · filed 2026-02-25 | -$186.70M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $671.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $564.90M derived: sum of 2 quarters · filed 2025-11-05 | $301.80M 10-Q · filed 2025-11-05 | $189.70M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$106.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$370.00M 10-Q · filed 2025-08-06 | -$482.10M derived: sum of 3 quarters · filed 2026-02-25 | -$406.80M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$263.10M 10-Q · filed 2025-05-06 | -$375.20M derived: sum of 2 quarters · filed 2026-02-25 | -$299.90M derived: sum of 3 quarters · filed 2026-02-25 | -$356.10M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$112.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$36.80M derived: sum of 2 quarters · filed 2026-02-25 | -$93.00M derived: sum of 3 quarters · filed 2026-02-25 | -$5.80M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $75.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $19.10M derived: sum of 2 quarters · filed 2024-11-06 | $106.30M 10-Q · filed 2024-11-06 | $91.90M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | -$56.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $31.00M 10-Q · filed 2024-07-31 | $16.60M derived: sum of 3 quarters · filed 2025-02-28 | -$24.30M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $87.20M 10-Q · filed 2024-04-29 | $72.80M derived: sum of 2 quarters · filed 2025-02-28 | $31.90M derived: sum of 3 quarters · filed 2025-02-28 | -$1.30M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$55.30M derived: sum of 2 quarters · filed 2025-02-28 | -$88.50M derived: sum of 3 quarters · filed 2025-02-28 | -$5.60M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$40.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$74.10M derived: sum of 2 quarters · filed 2023-10-27 | $8.80M 10-Q · filed 2023-10-27 | $41.80M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2022-06-30 | -$33.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $49.70M 10-Q · filed 2023-07-28 | $82.70M derived: sum of 3 quarters · filed 2024-02-12 | $88.50M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2022-03-31 | $82.90M 10-Q · filed 2023-04-28 | $115.90M derived: sum of 2 quarters · filed 2024-02-12 | $121.70M derived: sum of 3 quarters · filed 2024-02-12 | $130.80M derived: sum of 4 quarters · filed 2024-02-12 | ||
| 2021-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $38.80M derived: sum of 2 quarters · filed 2024-02-12 | $47.90M derived: sum of 3 quarters · filed 2024-02-12 | $62.00M 10-K · filed 2024-02-12 | ||
| 2021-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $14.90M derived: sum of 2 quarters · filed 2022-10-28 | $29.00M 10-Q · filed 2022-10-28 | $41.70M derived: sum of 4 quarters · filed 2023-02-13 | ||
| 2021-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $23.20M 10-Q · filed 2022-07-29 | $35.90M derived: sum of 3 quarters · filed 2023-02-13 | -$38.80M derived: sum of 4 quarters · filed 2023-02-13 | ||
| 2021-03-31 | $14.10M 10-Q · filed 2022-04-28 | $26.80M derived: sum of 2 quarters · filed 2023-02-13 | -$47.90M derived: sum of 3 quarters · filed 2023-02-13 | -$71.00M derived: sum of 4 quarters · filed 2023-02-13 | ||
| 2020-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$62.00M derived: sum of 2 quarters · filed 2023-02-13 | -$85.10M derived: sum of 3 quarters · filed 2023-02-13 | -$52.90M 10-K · filed 2023-02-13 | ||
| 2020-09-30 | -$74.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$97.80M derived: sum of 2 quarters · filed 2021-10-29 | -$65.60M 10-Q · filed 2021-10-29 | -$39.40M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-06-30 | -$23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $9.10M 10-Q · filed 2021-07-30 | $35.30M derived: sum of 3 quarters · filed 2022-02-14 | $55.80M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-03-31 | $32.20M 10-Q · filed 2021-04-28 | $58.40M derived: sum of 2 quarters · filed 2022-02-14 | $78.90M derived: sum of 3 quarters · filed 2022-02-14 | $91.70M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2019-12-31 | $26.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $46.70M derived: sum of 2 quarters · filed 2022-02-14 | $59.50M derived: sum of 3 quarters · filed 2022-02-14 | $43.20M 10-K · filed 2022-02-14 | ||
| 2019-09-30 | $20.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $33.30M derived: sum of 2 quarters · filed 2020-10-26 | $17.00M 10-Q · filed 2020-10-26 | $67.80M derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-06-30 | $12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | -$3.50M 10-Q · filed 2020-07-27 | $47.30M derived: sum of 3 quarters · filed 2021-02-12 | $27.60M derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-03-31 | -$16.30M 10-Q · filed 2020-04-28 | $34.50M derived: sum of 2 quarters · filed 2021-02-12 | $14.80M derived: sum of 3 quarters · filed 2021-02-12 | -$214.00M derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2018-12-31 | $50.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $31.10M derived: sum of 2 quarters · filed 2021-02-12 | -$197.70M derived: sum of 3 quarters · filed 2021-02-12 | -$157.80M 10-K · filed 2021-02-12 | ||
| 2018-09-30 | -$19.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | -$248.50M derived: sum of 2 quarters · filed 2019-10-25 | -$208.60M 10-Q · filed 2019-10-25 | $140.10M derived: sum of 4 quarters · filed 2020-02-14 | ||
| 2018-06-30 | -$228.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$188.90M 10-Q · filed 2019-07-26 | $159.80M derived: sum of 3 quarters · filed 2020-02-14 | $150.80M derived: sum of 4 quarters · filed 2020-02-14 | ||
| 2018-03-31 | $39.90M 10-Q · filed 2019-04-26 | -$6.70M 10-Q · filed 2018-04-27 | $388.60M derived: sum of 2 quarters · filed 2020-02-14 | $379.60M derived: sum of 3 quarters · filed 2020-02-14 | $314.60M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2017-12-31 | $348.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $339.70M derived: sum of 2 quarters · filed 2020-02-14 | $274.70M derived: sum of 3 quarters · filed 2020-02-14 | $293.70M 10-K · filed 2020-02-14 | $278.40M 10-K · filed 2018-02-16 | |
| 2017-09-30 | -$9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$74.00M derived: sum of 2 quarters · filed 2018-10-26 | -$55.00M 10-Q · filed 2018-10-26 | -$22.80M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2017-06-30 | -$65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$46.00M 10-Q · filed 2018-07-27 | -$13.80M derived: sum of 3 quarters · filed 2019-02-15 | -$1.80M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2017-03-31 | $19.00M 10-Q · filed 2018-04-27 | $51.20M derived: sum of 2 quarters · filed 2019-02-15 | $63.20M derived: sum of 3 quarters · filed 2019-02-15 | $99.30M derived: sum of 4 quarters · filed 2019-02-15 | ||
| 2016-12-31 | $32.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $44.20M derived: sum of 2 quarters · filed 2019-02-15 | $80.30M derived: sum of 3 quarters · filed 2019-02-15 | $105.10M 10-K · filed 2019-02-15 | ||
| 2016-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $48.10M derived: sum of 2 quarters · filed 2017-10-27 | $72.90M 10-Q · filed 2017-10-27 | $143.50M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $36.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $60.90M 10-Q · filed 2017-07-28 | $131.50M derived: sum of 3 quarters · filed 2018-02-16 | $150.50M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $24.80M 10-Q · filed 2017-04-28 | $95.40M derived: sum of 2 quarters · filed 2018-02-16 | $114.40M derived: sum of 3 quarters · filed 2018-02-16 | $132.70M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2015-12-31 | $70.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $89.60M derived: sum of 2 quarters · filed 2018-02-16 | $107.90M derived: sum of 3 quarters · filed 2018-02-16 | $134.50M 10-K · filed 2018-02-16 | ||
| 2015-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $37.30M derived: sum of 2 quarters · filed 2016-10-28 | $63.90M 10-Q · filed 2016-10-28 | $79.50M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-06-30 | $18.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $44.90M 10-Q · filed 2016-07-29 | $60.50M derived: sum of 3 quarters · filed 2017-02-17 | -$77.90M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-03-31 | $26.60M 10-Q · filed 2016-04-29 | $42.20M derived: sum of 2 quarters · filed 2017-02-17 | -$96.20M derived: sum of 3 quarters · filed 2017-02-17 | $139.70M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2014-12-31 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$122.80M derived: sum of 2 quarters · filed 2017-02-17 | $113.10M derived: sum of 3 quarters · filed 2017-02-17 | $128.10M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | -$138.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $97.50M derived: sum of 2 quarters · filed 2015-10-29 | $112.50M 10-Q · filed 2015-10-29 | |||
| 2014-06-30 | $235.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $250.90M 10-Q · filed 2015-07-29 | ||||
| 2014-03-31 | $15.00M 10-Q · filed 2015-04-29 | |||||
| 2013-12-31 | $80.60M 10-K · filed 2016-02-19 | |||||
| 2012-12-31 | $85.40M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |